Search research articles
Contact Us
Filters
Showing results (1-10 of 110) with videos related to
Page
of 11
Sort By:
Seminars in Oncology
|
April 12, 2017
Commentary: Prostate cancer screening-A long run for a short slide
Howard L Parnes
The American Journal of Bioethics : AJOB
|
December 8, 2011
Prostate cancer prevention: do the 5-ARIs make the grade?
Howard L Parnes
Pharmacotherapy
|
September 27, 2006
Chemoprevention in prostate cancer
Howard L Parnes, William D Figg
BJU International
|
September 24, 2013
Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial
Paul F Pinsky, Howard L Parnes, Gerald Andriole
Journal of the National Cancer Institute
|
May 6, 2004
Science peels the onion of selenium effects on prostate carcinogenesis
Philip R Taylor, Howard L Parnes, Scott M Lippman
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
February 18, 2014
Prostate cancer prevention: agent development strategies
Howard L Parnes, Margaret G House, Joseph A Tangrea
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2005
Prevention of hormone-related cancers: prostate cancer
Howard L Parnes, Ian M Thompson, Leslie G Ford
Current Opinion in Oncology
|
March 23, 2013
Prostate cancer prevention: strategies for agent development
Howard L Parnes, Margaret G House, Joseph A Tangrea
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2006
Early treatment gets the benefit
James L Gulley, Howard L Parnes, John Wright, et al.
Urology
|
June 29, 2021
Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening
Dudith Pierre-Victor, Howard L Parnes, Gerald L Andriole, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 110) with videos related to
Sort By:
Page
of 11
Seminars in Oncology
|
April 12, 2017
Commentary: Prostate cancer screening-A long run for a short slide
Howard L Parnes
The American Journal of Bioethics : AJOB
|
December 8, 2011
Prostate cancer prevention: do the 5-ARIs make the grade?
Howard L Parnes
Pharmacotherapy
|
September 27, 2006
Chemoprevention in prostate cancer
Howard L Parnes, William D Figg
BJU International
|
September 24, 2013
Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial
Paul F Pinsky, Howard L Parnes, Gerald Andriole
Journal of the National Cancer Institute
|
May 6, 2004
Science peels the onion of selenium effects on prostate carcinogenesis
Philip R Taylor, Howard L Parnes, Scott M Lippman
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
February 18, 2014
Prostate cancer prevention: agent development strategies
Howard L Parnes, Margaret G House, Joseph A Tangrea
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2005
Prevention of hormone-related cancers: prostate cancer
Howard L Parnes, Ian M Thompson, Leslie G Ford
Current Opinion in Oncology
|
March 23, 2013
Prostate cancer prevention: strategies for agent development
Howard L Parnes, Margaret G House, Joseph A Tangrea
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2006
Early treatment gets the benefit
James L Gulley, Howard L Parnes, John Wright, et al.
Urology
|
June 29, 2021
Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening
Dudith Pierre-Victor, Howard L Parnes, Gerald L Andriole, et al.
Page
of 11